Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1

被引:33
作者
Catalano, John G. [1 ]
Gudmundsson, Kristjan S. [1 ]
Svolto, Angilique [1 ]
Boggs, Sharon D. [1 ]
Miller, John F. [1 ]
Spaltenstein, Andrew [1 ]
Thomson, Michael [2 ]
Wheelan, Pat [3 ]
Minick, Doug J. [4 ]
Phelps, Dean P. [4 ]
Jenkinson, Stephen [5 ]
机构
[1] GlaxoSmithKline Res & Dev Ltd, Dept Med Chem, Infect Dis Ctr Excellence Drug Discovery, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline Res & Dev Ltd, Dept Virol, Infect Dis Ctr Excellence Drug Discovery, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline Res & Dev Ltd, Dept DMPK, Infect Dis Ctr Excellence Drug Discovery, Res Triangle Pk, NC 27709 USA
[4] GlaxoSmithKline Res & Dev Ltd, Dept Analyt Chem, Infect Dis Ctr Excellence Drug Discovery, Res Triangle Pk, NC 27709 USA
[5] GlaxoSmithKline Res & Dev Ltd, Dept Biochem & Analyt Pharmacol, Infect Dis Ctr Excellence Drug Discovery, Res Triangle Pk, NC 27709 USA
关键词
CXCR4; HIV; AIDS; Inhibitor; Antiviral; Viral; Entry; Chemokine; VIBRATIONAL CIRCULAR-DICHROISM; IMMUNODEFICIENCY-VIRUS TYPE-1; ABSOLUTE-CONFIGURATION; CHIRAL MOLECULES; INHIBITION; ENTRY;
D O I
10.1016/j.bmcl.2010.02.030
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Stereorandom and diastereoselective syntheses of a novel 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system are described. Derivatives of all four diastereomers were prepared and isolated in >98% ee. The pure enantiomers were compared in order to determine the preferred absolute and relative configuration required for optimal anti-HIV activity. Anti-HIV potency and pharmacokinetic properties of the newly synthesized tricyclic octahydrophenanthroline inhibitors are presented and comparisons are made to previously reported bicyclic (8S)-N-methyl-5,6,7,8-tetrahydro-8-quinolinamine analogs. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2186 / 2190
页数:5
相关论文
共 21 条
[1]   Sequential amination/annulation/aromatization reaction of carbonyl compounds and propargylamine: A new one-pot approach to functionalized pyridines [J].
Abbiati, G ;
Arcadi, A ;
Bianchi, G ;
Di Giuseppe, S ;
Marinelli, F ;
Rossi, E .
JOURNAL OF ORGANIC CHEMISTRY, 2003, 68 (18) :6959-6966
[2]   Solution phase combinatorial chemistry. Discovery of 13- and 15-membered polyazapyridinocyclophane libraries with antibacterial activity [J].
An, HY ;
Wang, TM ;
Mohan, V ;
Griffey, RH ;
Cook, PD .
TETRAHEDRON, 1998, 54 (16) :3999-4012
[3]  
[Anonymous], GAUSSIAN 03
[4]   A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains [J].
Berson, JF ;
Long, D ;
Doranz, BJ ;
Rucker, J ;
Jirik, FR ;
Doms, RW .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6288-6295
[5]  
BRIDGER GJ, 2003, Patent No. 2003055876
[6]  
Cashen Amanda F, 2007, Future Oncol, V3, P19, DOI 10.2217/14796694.3.1.19
[7]   AMD070, a CXCR4 chemokine receptor antagonist: Practical large-scale laboratory synthesis [J].
Crawford, Jason B. ;
Chen, Gang ;
Gauthier, David ;
Wilson, Trevor ;
Carpenter, Bryon ;
Baird, Lan R. ;
McEachern, Ernie ;
Kaller, Alan ;
Harwig, Curtis ;
Atsma, Bem ;
Skerlj, Renato T. ;
Bridger, Gary J. .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2008, 12 (05) :823-830
[8]  
CRAWFORD JB, 2006, Patent No. 2006039250
[9]   Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 [J].
Crump, MP ;
Gong, JH ;
Loetscher, P ;
Rajarathnam, K ;
Amara, A ;
Arenzana-Seisdedos, F ;
Virelizier, JL ;
Baggiolini, M ;
Sykes, BD ;
Clark-Lewis, I .
EMBO JOURNAL, 1997, 16 (23) :6996-7007
[10]   The bicyclam AMD3 100 story [J].
De Clercq, E .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (07) :581-587